Brooks 1996.

Methods	Randomised controlled trials. The authors report that they randomly allocated the patients into 3 groups but do not define the method of randomisation.
Participants	60 individuals enrolled and completed the study and were allocated to 3 groups, each with 20 people. The age of participants was unclear. We therefore categorised the study as awaiting assessment until we are able to get more information
Interventions	Group 1: loratadine (Claritin, Schering Plough) (LOR) once a day, plus a placebo spray twice a day Group 2: beclomethasone (Vancenase AQ, Schering‐Plough) (BEC) 2 sprays (about 84 mcg) each side of the nose twice a day, plus placebo LOR Group 3: BEC twice a day plus LOR once daily During the treatment comparison, subjects took no other treatment that might affect their hay fever
Outcomes	1) Symptom severity diaries recorded the level of discomfort perceived by the subjects for each of the 5 classes of seasonal allergic rhinitis symptoms 2) Subjective global assessment by the patient
Notes	The authors did not report the age of participants and we were unable to evaluate whether it could be included or not